A Lancet Psychiatry study of 70,000+ US adults with schizophrenia and diabetes found the link, but outside experts warn it can't show the drugs cause it.
Recap by typeshit. Full story at Quartz.
PHL17 shares findings that people on Ozempic and similar drugs are cutting alcohol spending at bars, restaurants and home.
Omer Raheem says he presented his team's work on GLP-1 therapies past weight loss at the ISSM Journals Webinar 2026.
The rundown covers CagriSema, retatrutide, MariTide, VK2735 and Roche's enicepatide, which the company says cut weight by 15.5% on average in a mid-stage trial.
Zhavoronkov links recorded ARDD 2026 sessions, among them Lilly's Kevin Duffin speaking on tirzepatide and aging clocks.
She notes tirzepatide is prescribed for type 2 diabetes and, for eligible patients, weight management, and says it isn't a fit for everyone.
AP reports the interim access policy would have FDA hold off on enforcement against pharmacies, despite agency scientists saying the peptides lack safety data.
Loading…